منابع مشابه
Onco-nephrology: tumor lysis syndrome.
Tumor lysis syndrome (TLS) describes the clinical and laboratory sequelae that result from the rapid release of intracellular contents of dying cancer cells. It is characterized by the release of potassium, phosphorous, and nucleic acids from cancer cells into the blood stream, with the potential to cause hyperkalemia; hyperphosphatemia and secondary hypocalcemia; hyperuricemia; AKI; and, shoul...
متن کاملOnco-nephrology: Core Curriculum 2015.
From Zablocki VAMC, Medical College of Wisconsin, Milwaukee, WI; CHU Université de Liège, Liège, Belgium; Hôpital de la Salpetrière, Paris, France; and Katholieke Universiteit Leuven, Leuven, Belgium. Received January 20, 2015. Accepted in revised form April 6, 2015. Originally published online June 6, 2015. Current affiliation: Baltimore VAMC and the University of Maryland School of Medicine, ...
متن کاملOnco-nephrology: AKI in the cancer patient.
AKI is common in patients with cancer, and it causes interruptions in therapy and increased hospital length of stay, cost, and mortality. Although cancer patients are susceptible to all of the usual causes of AKI in patients without cancer, there are a number of AKI syndromes that occur more frequently or are unique to this patient population. AKI also confers substantially increased risk of sh...
متن کاملOnco-nephrology: glomerular diseases with cancer.
Glomerular diseases occurring in the course of malignancies remain rare. Diverse glomerular lesions can be observed in a variety of neoplasms and involve different pathophysiologic links between the glomerulopathy and the cancer. The pathophysiology of solid tumor-associated glomerulopathies remains obscure, whereas in hematologic malignancy-induced paraneoplastic glomerulopathies, a molecular ...
متن کاملOnco-nephrology: renal toxicities of chemotherapeutic agents.
Despite dramatic improvements in patient survival and drug tolerability, nephrotoxicity remains an important complication of chemotherapy. Adverse renal effects occur because of innate drug toxicity and a number of patient- and drug-related factors. To provide cutting edge care for these patients, nephrologists and oncologists must be familiar with the nephrotoxicity of these drugs, particularl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experimental & Molecular Medicine
سال: 2019
ISSN: 2092-6413
DOI: 10.1038/s12276-019-0213-7